Prognostic impact of <i>TP53</i> mutation in newly diagnosed diffuse large B‐cell lymphoma patients treated in the FIL‐DLCL04 trialAnnalisa Chiappella, Federica Melle, Riccardo Moia et al.|British Journal of Haematology|2021Cited by 39
Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levelsRiccardo Moia, Robin Foà, Donatella Talotta et al.|Blood Advances|2025Cited by 17
<i>TP53</i>, <i>CD36</i> Mutations and <i>CDKN2A</i> Loss Predict Poor Outcome in Mantle Cell Lymphoma: Molecular Analysis of the FIL V-Rbac Phase 2 TrialRiccardo Moia, Carlo Visco, Maria Elena Carazzolo et al.|Blood|2024Cited by 3
MOLECULAR CLUSTERING ON CTDNA IMPROVES THE PROGNOSTIC STRATIFICATION OF DLBCL PATIENTS COMPARED TO CTDNA LEVELSRiccardo Moia, Gianluca Gaïdano, Donatella Talotta et al.|Hematological Oncology|2023Cited by 1
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trialRiccardo Moia, Monica Balzarotti, Mohammad Almasri et al.|Blood Advances|2026Cited by 0